Valuation — not yet established
No valuation for Mantra Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($34.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Mantra Bio
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2023 | Later Stage VC (Series A2) | $9.0M | ▮ | ▮ |
| Jul 2020 | Early Stage VC (Series A) | $25.0M | ▮ | ▮ |
| Jan 2018 | Accelerator/Incubator | — | ▮ | ▮ |
How Mantra Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mantra Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Mantra Bio raised?
- Mantra Bio has raised $34.0M in total funding across 3 recorded rounds.
- When did Mantra Bio last raise?
- Mantra Bio last raised in Jan 2023 (Later Stage VC (Series A2)), raising $9.0M.